-
Reliance Industries
1,223.30 1,611.20(%) -
NSE
1,777.00 1,878.00(%) -
TCS
2,386.70 3,336.70(%) -
HCL Technologies
1,376.00 1,770.00(%) -
HDFC Bank
728.55 1,020.35(%) -
Infosys
1,126.40 1,727.85(%) -
Indian Hotels Co
752.50 757.10(%) -
Gallantt Ispat L
648.45 946.70(%) -
ICICI Bank
1,395.00 1,479.90(%) -
NMDC
70.56 70.15(%) -
Billionbrains
200.85 227.00(%) -
Axis Bank
1,294.40 1,418.30(%) -
Netweb Technol.
4,666.00 2,942.45(%) -
Bajaj Finance
975.00 1,177.60(%) -
HDB FINANC SER
536.65 536.65(%) -
Bharti Airtel
1,871.20 2,174.70(%) -
SS Retail
741.55 603.00(%) -
Eternal
324.35 368.40(%) -
Kotak Mah. Bank
448.85 452.98(%) -
MV Electrosystems
918.00 510.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Kobo Biotech Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 6012.0
- ISIN : INE881A01015
-
Today’s Low
4.43 -
Today’s High
4.47
-
Open
4.43 -
Perv Close
4.52 -
52W Low
1.99 -
52W High
9.99
Key Indicators
-
P/E(TTM)
0.00
-
Mar.Cap (₹Cr.)
10.55
-
Div & Yield %
0.00
-
Book Value(₹)
-57.98
-
Debt-Equity Ratio
-1.99
-
AGM Date
15-Oct-2026
-
EPS
0.00
-
P/E Ratio
0.00
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
10.55
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
23.83
-
BV (₹)
-58.00
-
Sales( ₹ in Cr.)
0.00
-
NP (in Cr.)
-5.23
-
NP Var(%)
-6.0
-
Div%
0.0
-
CPS (₹)
-0.50
-
EPS (₹)
-2.20
-
Traded Value (₹ in Lakhs)
10.55
-
52 Week High
9.99
-
52 Week Low
1.99
-
Price BSE
4.0
-
Price NSE
0.00
-
Market Capital( in Cr.)
10.55
-
P/C Ratio
-8.20
-
P/E Ratio
-1.80
-
Price Vs.BV
-2.20
-
15-Oct-2026( 11:49)
Corporate News - Kobo... - <p>Kobo Biotech Limited inform...
-
27-Jun-2026( 01:35)
Corporate News - Kobo... - Kobo Biotech announced that th...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.08 | 0.02 | 0.02 | 0.02 | 0.04 | 0.03 |
| Stock Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income | 0.08 | 0.02 | 0.02 | 0.02 | 0.04 | 0.03 |
| EXPENDITURE : | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Power and Fuel Cost | 0.04 | 0.14 | 0.12 | 0.10 | 0.28 | 0.42 |
| Employee Cost | 0.19 | 0.25 | 0.23 | 0.72 | 1.39 | 1.80 |
| Other Manufacturing Expenses | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling and Administration Expenses | 0.74 | 0.12 | 0.14 | 0.11 | 0.15 | 0.14 |
| Miscellaneous Expenses | 0.24 | 0.37 | 1.01 | 9.57 | 0.96 | -1.67 |
| Employee Benefit Expenses | 0.19 | 0.25 | 0.23 | 0.72 | 1.39 | 1.80 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 1.23 | 0.87 | 1.50 | 10.50 | 2.79 | 0.69 |
| Operating Profit | -1.16 | -0.86 | -1.48 | -10.49 | -2.75 | -0.66 |
| Interest | 0.00 | 0.00 | 0.00 | 0.13 | 10.84 | 14.47 |
| Gross Profit | -1.16 | -0.86 | -1.48 | -10.62 | -13.59 | -15.13 |
| Depreciation | 4.07 | 4.07 | 4.07 | 4.61 | 5.64 | 5.88 |
| Profit Before Tax | -5.23 | -4.93 | -5.55 | -15.23 | -19.23 | -21.01 |
| Current Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Net Profit | -5.23 | -4.93 | -5.55 | -15.23 | -19.23 | -21.01 |
| Extraordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Net Profit | -5.23 | -4.93 | -5.55 | -15.23 | -19.23 | -21.01 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance brought forward | -202.34 | -197.41 | -191.86 | -176.63 | -157.40 | -136.39 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | -207.57 | -202.34 | -197.41 | -191.86 | -176.63 | -157.40 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | -2.20 | -2.07 | -2.33 | -6.39 | -8.07 | -8.82 |
| Earnings Per Share(Adj)-Unit Curr | -2.20 | -2.07 | -2.33 | -6.39 | -8.07 | -8.82 |
| Book Value | -57.98 | -55.79 | -53.72 | -51.39 | -45.00 | -36.92 |
| Book Value(Adj)-Unit Curr | -57.98 | -55.79 | -53.72 | -51.39 | -45.00 | -36.92 |
